CORC

浏览/检索结果: 共19条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang
收藏  |  浏览/下载:92/0  |  提交时间:2022/03/28
Characterization of covalent binding of tyrosine kinase inhibitors to plasma proteins 期刊论文
DRUG METABOLISM AND PHARMACOKINETICS, 2020, 卷号: 35, 期号: 5, 页码: 456-465
作者:  Liu, Xiaoyun;  Feng, Dan;  Zheng, Mingyue;  Cui, Yongmei;  Zhong, Dafang
收藏  |  浏览/下载:13/0  |  提交时间:2020/12/21
Design, synthesis and biological study of potent and covalent HER-2 tyrosine kinase inhibitors with low cytotoxicity in vitro 期刊论文
CHEMICAL PAPERS, 2019, 卷号: 73, 期号: 6, 页码: 1333-1345
作者:  Jin, Shuyu;  Sun, Xiuyun;  Liu, Dan;  Xie, Hua;  Rao, Yu
收藏  |  浏览/下载:7/0  |  提交时间:2020/07/01
The impact of neratinib with or without anti-diarrheal prophylaxis on health-related quality of life in HER2+early-stage breast cancer: Analyses from the ExteNET and CONTROL trials 会议论文
作者:  Delaloge, S.;  Hurvitz, S.;  Chan, N.;  Bose, R.;  Jankowitz, R. C.
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/05
Risk of gastrointestinal events during neratinib therapy in patients with cancer: a systematic review and meta-analysis of clinical trials 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 卷号: 12, 期号: 4
作者:  Chen, Peng;  Chen, Fuchao;  Zhou, Benhong
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Neratinib-based therapy in patients with metastatic HER2-positive breast cancer from Asia 期刊论文
2019
作者:  Xu Binghe;  Kim Sung-Bae;  Inoue Kenichi;  Lee JuRueyJiuan;  Zhang Bo
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer 期刊论文
2019, 卷号: 15, 期号: 21, 页码: 2489-2501
作者:  Iwata Hiroji;  Masuda Norikazu;  Kim Sung-Bae;  Inoue Kenichi;  Rai Yoshiaki
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
Efficacy, safety and tolerability of neratinib-based therapy in patients from Asia with metastatic HER2+breast cancer and other solid tumors: A pooled analysis of 6 clinical trials 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Kim, Sung-Bae;  Inoue, Kenichi;  Shen, Zhen-Zhou;  Lee, Ju RueyJiuan
收藏  |  浏览/下载:14/0  |  提交时间:2020/01/03
Efficacy, safety and tolerability of neratinib-based therapy in patients from Asia with metastatic HER2+breast cancer and other solid tumors: A pooled analysis of 6 clinical trials 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Kim, Sung-Bae;  Inoue, Kenichi;  Shen, Zhen-Zhou;  Lee, Ju RueyJiuan
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Metabolic profiles of neratinib in rat by using ultra-high-performance liquid chromatography coupled with diode array detector and Q-Exactive Orbitrap tandem mass spectrometry 期刊论文
Biomedical Chromatography, 2018, 卷号: 32, 期号: 9, 页码: e4272
作者:  Liu, Wen*;  Li, Sha;  Wu, Yangke;  Yan, Xiao;  Zhu, Y. -M.
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/27


©版权所有 ©2017 CSpace - Powered by CSpace